+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update

  • ID: 4721924
  • Company Profile
  • 38 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Dignitana AB
  • Elekta AB
  • Micropos Medical AB
  • OraSolv AB
  • SpectraCure AB
  • MORE
Summary

Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a precise and safe treatment. It also comprises a laser applicator with introducer that is used for positioning of the fiber, depending on the tumor size. TRANBERG is developed for immune stimulating interstitial thermotherapy (imILT). CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its products to hospitals and clinics. CLS is headquartered Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Dignitana AB
  • Elekta AB
  • Micropos Medical AB
  • OraSolv AB
  • SpectraCure AB
  • MORE
Clinical Laserthermia Systems AB Company Overview
Clinical Laserthermia Systems AB Company Snapshot
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
Clinical Laserthermia Systems AB – Pipeline Analysis Overview
Business Description
Clinical Laserthermia Systems AB - Key Facts
Clinical Laserthermia Systems AB - Major Products and Services
Clinical Laserthermia Systems AB Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status

Clinical Laserthermia Systems AB Pipeline Products Overview
CLS Cancer Immunotherapy System - Prostate Cancer
CLS Cancer Immunotherapy System - Prostate Cancer Product Overview
CLS Cancer Immunotherapy System - Prostate Cancer Clinical Trial
imILT Software
imILT Software Product Overview
imILT Software Clinical Trial
TRANBERG Cancer Immunotherapy System - Breast Cancer
TRANBERG Cancer Immunotherapy System - Breast Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Breast Cancer Clinical Trial
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Clinical Trial
TRANBERG Cancer Immunotherapy System - Skin Cancer
TRANBERG Cancer Immunotherapy System - Skin Cancer Product Overview
TRANBERG Cancer Immunotherapy System - Solid Cancers
TRANBERG Cancer Immunotherapy System - Solid Cancers Product Overview
TRANBERG Cancer Immunotherapy System - Solid Cancers Clinical Trial

Clinical Laserthermia Systems AB - Key Competitors

Clinical Laserthermia Systems AB - Key Employees
Clinical Laserthermia Systems AB - Key Employee Biographies

Clinical Laserthermia Systems AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments

Clinical Laserthermia Systems AB, Recent Developments
Jun 18, 2018: CLS receives new order for single use products from UTMB in the U.S., for treatment of early stage prostate cancer
Apr 19, 2018: First patients treated with CLS TRANBERG-system in the clinical study at Toronto General Hospital, Canada
Apr 19, 2018: CLS participates with hands-on workshop at the European Conference on Interventional Oncology
Apr 17, 2018: Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer
Apr 11, 2018: Clinical Laserthermia Systems Exhibits MRI-Guided Laser Ablation System at Southwest Prostate Cancer Symposium
Apr 04, 2018: CLS quality processes received good marks by American authority FDA
Mar 16, 2018: CLS and Toronto General Hospital, Canada, carry out clinical study regarding MRI guided FLA treatment of prostate cancer
Mar 14, 2018: CLS receives new order for the TRANBERG-system from UTMB in the U.S.
Mar 08, 2018: CLS imILT treatment of pancreatic cancer shows positive trend regarding survival
Jan 02, 2018: CLS single use accessories evaluated by Laser Prostate Centers of America

Appendix
Methodology
About
Contact Us
Disclaimer

List of Tables
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
Clinical Laserthermia Systems AB Pipeline Products by Indication
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Clinical Laserthermia Systems AB, Key Facts
Clinical Laserthermia Systems AB, Major Products and Services
Clinical Laserthermia Systems AB Number of Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Pipeline Products Summary by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Clinical Laserthermia Systems AB Ongoing Clinical Trials Summary
CLS Cancer Immunotherapy System - Prostate Cancer - Product Status
CLS Cancer Immunotherapy System - Prostate Cancer - Product Description
CLS Cancer Immunotherapy System - Prostate Cancer - Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
CLS Cancer Immunotherapy System - Prostate Cancer - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study
imILT Software - Product Status
imILT Software - Product Description
imILT Software - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Breast Cancer - Interstitial Laser Thermotherapy (imILT) as a Treatment option in Breast Cancer Patients not suitable for Surgical Excision
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - An Open-label, Comparative Trial to Evaluate the Effect of imILT in Patients with Advanced Disease or Stage IV Pancreatic Carcinoma
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Status
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Description
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Status
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Description
TRANBERG Cancer Immunotherapy System - Solid Cancers - To Evaluate the Safety and Palliative Treatment Effect on Patients with Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT)
Clinical Laserthermia Systems AB, Key Employees
Clinical Laserthermia Systems AB, Key Employee Biographies
Clinical Laserthermia Systems AB, Subsidiaries
Glossary

List of Figures
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
Clinical Laserthermia Systems AB Pipeline Products by Development Stage
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • SpectraCure AB
  • Seno Medical Instruments Inc
  • OraSolv AB
  • Micropos Medical AB
  • Elekta AB
  • Dignitana AB
Note: Product cover images may vary from those shown
Adroll
adroll